FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to using a phospholipid emulsion containing an effective amount of dihydroquercetin in patients with ischemic organ and extremity injuries.
EFFECT: invention can be used in surgery, cardiology, resuscitation, emergency medicine, rehabilitation, including myocardial infarction (MI), as well as in pharmacology for creating new medicinal compositions in treating patients with ischemia-reperfusion syndrome.
5 cl, 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CARDIOPROTECTION OF ISCHEMIC AND REPERFUSION INJURIES IN ACUTE MYOCARDIAL INFARCTION | 2019 |
|
RU2712448C1 |
APPLICATION OF A PHOSPHOLIPID EMULSION CONTAINING AN EFFECTIVE AMOUNT OF DIHYDROQUERCETIN FOR TREATING GESTOSES OF THE FIRST TRIMESTER OF PREGNANCY | 2021 |
|
RU2773682C1 |
METHOD OF TREATMENT OF ACUTE MYOCARDIAL INFARCTION | 2006 |
|
RU2343921C2 |
METHOD FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION | 2005 |
|
RU2299730C1 |
METHOD FOR TREATING ACUTE MYOCARDIAL INFARCTION CASES | 2004 |
|
RU2267323C1 |
METHOD FOR REDUCING THE SIZE OF ISCHEMIC-REPERFUSION MYOCARDIAL INJURY WITH THE USE OF QUINACRINE | 2019 |
|
RU2716596C1 |
USE OF A PHOSPHOLIPID EMULSION CONTAINING AN EFFECTIVE AMOUNT OF DIHYDROQUERCETIN, LECITHIN AND GLYCINE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY SYSTEM | 2021 |
|
RU2757360C1 |
CARDIOPROTECTION TECHNIQUE | 2010 |
|
RU2456024C2 |
APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
Authors
Dates
2022-03-15—Published
2021-03-24—Filed